Equities

Panion & BF Biotech Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1760:TAI

Panion & BF Biotech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)61.60
  • Today's Change-0.70 / -1.12%
  • Shares traded118.88k
  • 1 Year change-28.37%
  • Beta-0.1076
Data delayed at least 20 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

PANION & BF BIOTECH INC. is a Taiwan-based company principally engaged in the manufacture and sales of western medicines and experimental drugs. The Company is also involved in the manufacture and sales of various kinds of cosmetics. The Company's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The Company also provides biotechnology services. The Company distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.

  • Revenue in TWD (TTM)2.04bn
  • Net income in TWD174.37m
  • Incorporated1976
  • Employees321.00
  • Location
    Panion & BF Biotech Inc16F, Building FNo. 3, Yuanqu Street, Nangang DistrictTAIPEI 115TaiwanTWN
  • Phone+886 226558218
  • Fax+886 226558318
  • Websitehttps://www.pbf.com.tw/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nang Kuang Pharmaceutical Co Ltd2.22bn257.07m3.74bn552.0014.571.548.471.682.542.5421.9824.030.60732.198.36--7.026.6410.089.5636.3434.5011.5611.940.708410.040.223180.052.314.5422.682.2852.41-1.21
Formosa Pharmaceuticals Inc12.16m-74.25m4.10bn----2.71--336.98-0.5083-0.50830.081810.000.0057--4.64---3.49-30.53-3.80-33.884.52---610.20-758.219.55--0.0161--359.89163.5237.56--103.21--
Cenra Inc8.68bn293.68m5.08bn1.40k12.300.66637.970.58472.762.7678.3650.880.69761.985.75--2.373.493.584.7038.9636.763.395.220.72946.480.29450.314.012.28-1.53-3.78-8.434.92
Panion & BF Biotech Inc2.04bn174.37m5.28bn321.0030.312.7816.712.592.032.0323.7722.180.65111.729.45--5.573.468.144.9053.7452.048.555.280.836315.900.2529123.317.855.2261.26-5.0510.700.3601
Sinphar Pharmaceutical Co Ltd3.35bn345.57m5.81bn984.0016.841.769.871.741.811.8117.5717.390.54012.536.94--5.401.397.001.9142.5137.5910.003.111.5613.850.318869.666.335.64-18.7885.267.7540.11
SCI Pharmtech Inc1.39bn115.35m6.21bn241.0054.041.1617.004.470.96230.962311.6144.940.19741.604.99--1.645.961.897.0524.9135.308.3021.640.38412.560.150625.2426.54-8.3481.42-1.3135.86-18.67
Formosa Laboratories Inc4.90bn240.77m6.82bn480.0028.590.89489.231.391.981.9840.6363.360.35651.565.42--1.472.652.013.6041.8438.164.128.391.231.590.290841.088.5011.3824.5868.35-16.19--
Data as of Feb 11 2026. Currency figures normalised to Panion & BF Biotech Inc's reporting currency: Taiwan Dollar TWD

Institutional shareholders

4.21%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 07 Jan 20262.48m2.89%
Dimensional Fund Advisors LPas of 08 Jan 2026959.68k1.12%
Vanguard Fiduciary Trust Co.as of 30 Nov 202562.57k0.07%
SSgA Funds Management, Inc.as of 08 Jan 202656.79k0.07%
DFA Australia Ltd.as of 31 Dec 202529.89k0.04%
Dimensional Fund Advisors Ltd.as of 30 Nov 202517.02k0.02%
Vanguard Asset Management Ltd.as of 31 Dec 20256.21k0.01%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.